S Mitchell1, R Ayesh, T Barrett, R Smith. 1. Molecular Toxicology, Division of Biomedical Sciences, Imperial College School of Medicine, London, England.
Abstract
BACKGROUND: In patients with various degrees of hepatocellular failure and portosystemic shunting of blood, the breath may acquire a sweet, musty, or even slightly faecal aroma, termed foetor hepaticus, which has been attributed mainly to volatile sulphur compounds with contributions from various nitrogenous substances. Not infrequently in such patients, unusual body odours are also encountered and, by analogy with the 'fish-odour syndrome' known to be caused by excessive trimethylamine, the availability of this latter graveolent amine to potentially contribute to odours associated with hepatic disease was investigated. METHODS: Urine (0-24 h) was collected from 63 patients with various liver diseases previously confirmed in hospital by means of various biochemical, immunologic, pathologic, and radiologic investigations. Total trimethylamine and trimethylamine N-oxide levels in urine were measured with head-space gas chromatography. RESULTS: In total, 50% (32 of 63) of the patients (primary liver disease, 25 of 47, or 53.2%; secondary liver disease, 7 of 16, or 43.8%) had urinary trimethylamine levels greater than the upper end of the range considered normal (0.08-1.84 microg/ml). Seventeen patients excreted large amounts of free trimethylamine (more than 10 microg/ml), above the threshold usually associated with the appearance of a 'fish-like' body odour and tainted breath. CONCLUSIONS: Excessive amounts of trimethylamine may well contribute to the overall body odour problems encountered among patients with severe hepatic disease, precipitating in these individuals a secondary form of the 'fish-odour syndrome'.
BACKGROUND: In patients with various degrees of hepatocellular failure and portosystemic shunting of blood, the breath may acquire a sweet, musty, or even slightly faecal aroma, termed foetor hepaticus, which has been attributed mainly to volatile sulphur compounds with contributions from various nitrogenous substances. Not infrequently in such patients, unusual body odours are also encountered and, by analogy with the 'fish-odour syndrome' known to be caused by excessive trimethylamine, the availability of this latter graveolent amine to potentially contribute to odours associated with hepatic disease was investigated. METHODS: Urine (0-24 h) was collected from 63 patients with various liver diseases previously confirmed in hospital by means of various biochemical, immunologic, pathologic, and radiologic investigations. Total trimethylamine and trimethylamine N-oxide levels in urine were measured with head-space gas chromatography. RESULTS: In total, 50% (32 of 63) of the patients (primary liver disease, 25 of 47, or 53.2%; secondary liver disease, 7 of 16, or 43.8%) had urinary trimethylamine levels greater than the upper end of the range considered normal (0.08-1.84 microg/ml). Seventeen patients excreted large amounts of free trimethylamine (more than 10 microg/ml), above the threshold usually associated with the appearance of a 'fish-like' body odour and tainted breath. CONCLUSIONS: Excessive amounts of trimethylamine may well contribute to the overall body odour problems encountered among patients with severe hepatic disease, precipitating in these individuals a secondary form of the 'fish-odour syndrome'.
Authors: Makiko Shimizu; Charles K Allerston; Elizabeth A Shephard; Hiroshi Yamazaki; Ian R Phillips Journal: Br J Clin Pharmacol Date: 2014-05 Impact factor: 4.335
Authors: Martin Kummen; Mette Vesterhus; Marius Trøseid; Bjørn Moum; Asbjørn Svardal; Kirsten Muri Boberg; Pål Aukrust; Tom Hemming Karlsen; Rolf Kristian Berge; Johannes Roksund Hov Journal: United European Gastroenterol J Date: 2016-08-02 Impact factor: 4.623
Authors: Giuseppina Campisi; Anna Musciotto; Olga Di Fede; Vito Di Marco; Antonio Craxì Journal: Intern Emerg Med Date: 2010-12-08 Impact factor: 3.397
Authors: Jun Zhang; Madhusudana R Chaluvadi; Rob Reddy; Meike S Motika; Terrilyn A Richardson; John R Cashman; Edward T Morgan Journal: Drug Metab Dispos Date: 2008-12-16 Impact factor: 3.922
Authors: Ibrahim A Hanouneh; Nizar N Zein; Frank Cikach; Luma Dababneh; David Grove; Naim Alkhouri; Rocio Lopez; Raed A Dweik Journal: Clin Gastroenterol Hepatol Date: 2013-09-10 Impact factor: 11.382